Monday 15 October 2018
Contact US    |    Archive
Channel News Asia
27 days ago

Viking Therapeutics liver drug succeeds in mid-stage study

REUTERS: Viking Therapeutics Inc said on Tuesday its experimental liver disease treatment met the main goals of a mid-stage trial by reducing cholesterol and liver fat in patients. The 12-week study tested Viking s VK2809 against a placebo in patients with non-alcoholic fatty liver disease (NAFLD) ...

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Viking

 | 

Therapeutics

 | 

liver

 | 

drug

 | 

succeeds

 | 

mid

 | 

stage

 | 

study

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)